Specifically, DCs from patients with rheumatoid arthritis (RA) exhibit an increased expression of CD14 and CD16 proteins on their surface, indicating a shift towards a pro-inflammatory phenotype. This evidence concerns the gene CD14 and rheumatoid arthritis.